<DOC>
	<DOCNO>NCT00002009</DOCNO>
	<brief_summary>To determine maximum tolerate dose ( MTD ) toxicity sargramostim ( recombinant granulocyte-macrophage colony-stimulating factor ; GM-CSF ) give continuous intravenous infusion ( CIV ) patient leukopenia association AIDS virus infection . In addition , single dose steady state pharmacokinetics also determine .</brief_summary>
	<brief_title>A Phase I/II Study Recombinant Human GM-CSF Patients With AIDS Virus Infection Leukopenia</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Leukopenia</mesh_term>
	<criteria>Inclusion Criteria Patients must : Met CDC criterion diagnosis AIDS . Total peripheral blood leukocyte count = &lt; 3000 cells/mm3 measure least two occasion separate minimum one week . Must recover one opportunistic infection . Serum antibody HTLVIII/LAV without viremia . Anticipated survival least 6 month . Exclusion Criteria Coexisting Condition : Patients follow condition symptom exclude : AIDS relate complex ( ARC ) . History malignancy Kaposi 's sarcoma ( KS ) . Excessive diarrhea ( 5 liquid nonliquid stool per day ) . Currently hospitalize hospitalize within last 4 week treatment opportunistic infection . Presence renal dysfunction . Other evidence primary hematologic infectious disorder unrelated AIDS virus infection . Patients follow exclude : AIDS relate complex ( ARC ) . History malignancy Kaposi 's sarcoma ( KS ) . Excessive diarrhea ( 5 liquid nonliquid stool per day ) . Currently hospitalize hospitalize within last 4 week treatment opportunistic infection . Dementia alter mental status would prohibit give understand informed consent . Prior Medication : Excluded : Any marrow suppressive medication trimethoprimsulfamethoxazole combination ( TMPPurposeX ) Fansidar . Excluded within 6 week study entry : Any investigational drug . Prior Treatment : Excluded within 6 week study entry : Systemic cytotoxic chemotherapy irradiation . Risk Behavior : Excluded within 3 month study entry : Regular , excessive use alcohol , hallucinogens agent addict .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 1988</verification_date>
	<keyword>Leukopenia</keyword>
	<keyword>Drug Evaluation</keyword>
	<keyword>Granulocyte-Macrophage Colony-Stimulating Factor</keyword>
</DOC>